Insider trade

MetLife (MET): EVP & Chief Risk Officer sold ~$1.74M

Marlene Debel, EVP & Chief Risk Officer at MetLife, sold ~$1.74M of MetLife shares.

~$1.74M
Approx. value · 21K sh @ $81.59
154K
Holds after · shares reported
Traded
Jun 1, 2026
Filed
Jun 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 30, 2025Federal contract · $3.5M obligatedDepartment of State awarded MetLife: $3.45M obligated to date
  2. Mar 27, 2026CongressDisclosed purchase of MET — reported range $1,001 - $15,000
  3. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.4%
  4. May 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  5. May 7, 20265% stakeBoard of Directors of MetLife, Inc., as an entity filed an activist stake (13D) of 16.2%
  6. Jun 1, 2026 · this disclosureInsiderOfficer sold ~$1.74M of MET shares in the open market

What came next

  1. Aug 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  2. Aug 6, 20265% stakeBoard of Directors of MetLife, Inc., as an entity filed an activist stake (13D) of 16.1%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for MetLife

For MetLife, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MET page.

Other recent filings by Marlene Debel, EVP & Chief Risk Officer

The full history of Marlene Debel, EVP & Chief Risk Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at MetLife

Everything OQRO holds on this company is on its MET page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data